Metraipolis › archive › dc_5cecc92aad7b

Transcriptome signatures for the identification of bevacizumab responders in ovarian cancer — Europe PMC PMID:42576234

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/42576234
DOI
10.1186/s13073-[numero omesso]-6
License (as archived)
solo-consultazione
Archived
2026-10-07T21:55:44.904Z
SHA-256 of the archived text
4cd2c8163e43313aa372595367ae42d1fb379d9632b9041f22fb46d721ebd20a
Stable URL of this page
https://metraipolis.com/documento/dc_5cecc92aad7b

How to cite

Transcriptome signatures for the identification of bevacizumab responders in ovarian cancer — Europe PMC PMID:42576234 — Europe PMC (en), https://europepmc.org/article/MED/42576234 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_5cecc92aad7b (Metraipolis archive dc_5cecc92aad7b, sha256 4cd2c8163e43313aa372595367ae42d1fb379d9632b9041f22fb46d721ebd20a)
BibTeX
@misc{dc5cecc92aad7b,
  title = {Transcriptome signatures for the identification of bevacizumab responders in ovarian cancer — Europe PMC PMID:42576234},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/42576234},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_5cecc92aad7b; sha256 4cd2c8163e43313aa372595367ae42d1fb379d9632b9041f22fb46d721ebd20a},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/42576234. Agents can read the archived copy with the MCP tool read_document.